CN1312116A - Liufukang oral liquid for supporting chemotherapy and radiotherapy of terminal cancer and its preparation method - Google Patents

Liufukang oral liquid for supporting chemotherapy and radiotherapy of terminal cancer and its preparation method Download PDF

Info

Publication number
CN1312116A
CN1312116A CN 01111427 CN01111427A CN1312116A CN 1312116 A CN1312116 A CN 1312116A CN 01111427 CN01111427 CN 01111427 CN 01111427 A CN01111427 A CN 01111427A CN 1312116 A CN1312116 A CN 1312116A
Authority
CN
China
Prior art keywords
gram
chemotherapy
liufukang
preparation
radiotherapy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN 01111427
Other languages
Chinese (zh)
Inventor
刘俊山
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN 01111427 priority Critical patent/CN1312116A/en
Publication of CN1312116A publication Critical patent/CN1312116A/en
Pending legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The present invention relates to a Chinese medicine Liufukang oral liquor matched with chemotherapy for curing late tumor and its preparation method. It is made from 14 Chinese medicinal materials of iron holly bark, hedyotis, bearded scutellaria, American ginseng, astragalus root, ovate atractylodes root, pinellia tuber and others through the processes of boiling by adding water to extract, filtering, heating, concentrating, regulating concentration, fine-filtering, filling, sealing and sterilizing to obtain the finished product. Said oral liquor possesses the functions of enriching supplementation and resisting cancer, increasing white blood cell, wheting appetite, obviously reducing toxic side effect of radiotherapy and chemotherapy and raising therapeutic effect.

Description

A kind of Liufukang oral liquid and preparation method that cooperates chemicotherapy treatment late tumor
The present invention relates to a kind of Liufukang oral liquid and preparation method that cooperates chemicotherapy treatment late tumor.
Patients with advanced cancer often because of can not operation or postoperative recurrence, transfer, needs radiotherapy, chemotherapy.But some chemotherapy and conventional radiotheraphy are still unsatisfactory and toxicity is bigger at present.
The present invention is directed to above-mentioned existing problems, a kind of Liufukang oral liquid and preparation method that cooperates chemicotherapy treatment late tumor is provided, take this medicine and can play the efficacy enhancing and toxicity reducing effect, obviously alleviate the toxic and side effects of chemicotherapy.
Embodiment of the present invention be according to oncological pathology principle and the traditional Chinese medical science in clinical mainly with blood circulation promoting and blood stasis dispelling, the body resistance strengthening and constitution consolidating, hard masses softening and resolving, dispelling phlegm and eliminating dampness, heat-clearing and toxic substances removing etc. form for the main rule of treatment, and concrete scheme is that this oral liquid is made by the raw material of following consumption: Cortex Ilicis Rotundae 30-50 gram, Herba Hedyotidis Diffusae 30-50 gram, Herba Scutellariae Barbatae 30-50 gram, Radix Panacis Quinquefolii 15-30 gram, Radix Astragali 15-30 gram, Rhizoma Atractylodis Macrocephalae 12-15 gram, Rhizoma Pinelliae 10-12 gram, Rhizoma Corydalis 12-15 gram, Scorpio 0.5 gram, Fructus Toosendan 10-15 gram, Carapax Trionycis 6-10 gram, Poria 10-15 gram, Pericarpium Citri Reticulatae 10-12 gram, Radix Glycyrrhizae 6-10 gram.Method for making is: above 14 kinds of raw materials add water octuple amount and boil extraction 1 hour, filter, and filtrate is deposited in addition, and medicinal residues add six times of amounts of water again, boil and extract 1 hour, filter squeezing medicinal residues, merge extractive liquid.80 ℃ are concentrated into every milliliter and are equivalent to crude drug 0.5 gram, and standing over night use filter paper filtering, and sugaring, benzoic acid are adjusted concentration and be equivalent to crude drug 0.4 gram to every milliliter, fine straining, and embedding is sterilized, promptly in 250 milliliters of infusion bottles.
The invention has the advantages that it belongs to the nourishing anticarcinogen, the energy promoting leucocytes, stimulating appetite, compared notable difference with simple chemicotherapy, having reduced toxicity has increased the effect of chemicotherapy simultaneously, make cancer patient on base therapy, improve its survival rate, and the WBC due to the antagonism radiotherapy and chemotherapy medicine toxicity descend and the alopecia effect preferably.For performing the operation, can not accept the patient of chemicotherapy again in addition, take the effect that this medicine also has the stable state of an illness, mitigation symptoms, improves its survival rate.

Claims (1)

1, a kind of Liufukang oral liquid and preparation method that cooperates chemicotherapy treatment late tumor, it is characterized in that it is to be made by the raw material of following consumption: Cortex Ilicis Rotundae 30-50 gram, Herba Hedyotidis Diffusae 30-50 gram, Herba Scutellariae Barbatae 30-50 gram, Radix Panacis Quinquefolii 15-30 gram, Radix Astragali 15-30 gram, Rhizoma Atractylodis Macrocephalae 12-15 gram, Rhizoma Pinelliae 10-12 gram, Rhizoma Corydalis 12-15 gram, Scorpio 0.5 gram, Fructus Toosendan 10-15 gram, Carapax Trionycis 6-10 gram, Poria 10-15 gram, Pericarpium Citri Reticulatae 10-12 gram, Radix Glycyrrhizae 6-10 gram, method for making is: above 14 kinds of raw materials add water octuple amount and boil extraction 1 hour, filter, filtrate is deposited in addition, medicinal residues add six times of amounts of water again, boil and extracted 1 hour, filter, the squeezing medicinal residues, merge extractive liquid,, 80 ℃ are concentrated into every milliliter and are equivalent to crude drug 0.5 gram, standing over night is used filter paper filtering, sugaring, benzoic acid, adjustment concentration is equivalent to crude drug 0.4 to every milliliter and restrains, fine straining, sterilization, promptly.
CN 01111427 2001-03-07 2001-03-07 Liufukang oral liquid for supporting chemotherapy and radiotherapy of terminal cancer and its preparation method Pending CN1312116A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN 01111427 CN1312116A (en) 2001-03-07 2001-03-07 Liufukang oral liquid for supporting chemotherapy and radiotherapy of terminal cancer and its preparation method

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN 01111427 CN1312116A (en) 2001-03-07 2001-03-07 Liufukang oral liquid for supporting chemotherapy and radiotherapy of terminal cancer and its preparation method

Publications (1)

Publication Number Publication Date
CN1312116A true CN1312116A (en) 2001-09-12

Family

ID=4659043

Family Applications (1)

Application Number Title Priority Date Filing Date
CN 01111427 Pending CN1312116A (en) 2001-03-07 2001-03-07 Liufukang oral liquid for supporting chemotherapy and radiotherapy of terminal cancer and its preparation method

Country Status (1)

Country Link
CN (1) CN1312116A (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102058744A (en) * 2010-11-25 2011-05-18 代龙 Chinese medicinal composition for treating malignant tumor and preparation method thereof
US8173177B2 (en) 2003-09-08 2012-05-08 Genyous Biomed International Inc. Compositions of botanical extracts for cancer therapy
CN115990229A (en) * 2021-11-09 2023-04-21 四川省中医药科学院 Composition for eliminating tumor, resolving masses and/or replenishing qi to invigorate spleen

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8173177B2 (en) 2003-09-08 2012-05-08 Genyous Biomed International Inc. Compositions of botanical extracts for cancer therapy
CN102058744A (en) * 2010-11-25 2011-05-18 代龙 Chinese medicinal composition for treating malignant tumor and preparation method thereof
CN115990229A (en) * 2021-11-09 2023-04-21 四川省中医药科学院 Composition for eliminating tumor, resolving masses and/or replenishing qi to invigorate spleen
CN115990229B (en) * 2021-11-09 2024-04-12 四川省中医药科学院 Composition for treating pulmonary nodules

Similar Documents

Publication Publication Date Title
CN102512587B (en) Decoction for treating viral myocarditis
CN104784347A (en) Health-preserving medicinal liquor and manufacturing method thereof
CN110496157B (en) Safflower Xiaoyao preparation for treating breast cancer and preparation method and application thereof
CN103182008A (en) Preparation method for traditional Chinese medicine used for stabilizing and reducing blood pressure
CN1056064C (en) Medicine for curing liver cancer and its making method
CN1312116A (en) Liufukang oral liquid for supporting chemotherapy and radiotherapy of terminal cancer and its preparation method
CN1408383A (en) Pure traditional Chinese medicine preparation for curing gastroinstestinal cancer and preparing method
CN114558074A (en) Traditional Chinese medicine composition for treating metabolic-related fatty liver disease and preparation method and application thereof
CN110215485B (en) Traditional Chinese medicine composition for treating diabetic skin ulcer and preparation method thereof
CN102397363A (en) Traditional Chinese medicine for treating hypertension
CN110893215A (en) Qi-tonifying and blood-nourishing medicinal liquor and preparation method thereof
CN1059336C (en) Oral liquor for curing senile dementia and constipation
CN101278982A (en) Chinese medicine compound preparation for curing acute or chronic hepatitis B and method of preparing the same
CN1772275A (en) Medicine for treating diseases of intestine, spleen and kidney and its making process
CN102614420A (en) Chinese medicine preparation for curing atrophic glossitis
CN103638469B (en) A kind of Chinese medicine for the treatment of coronary heart disease
CN107519370B (en) Compound preparation for treating non-allergic purpura caused by deficiency of spleen and kidney and preparation method thereof
CN101444616B (en) Medicated wine for curing chronic rheumatism and method for preparing same
CN1070373C (en) Medlar type health care oral liquid and preparing method thereof
CN107007802B (en) Compound Chinese medicine preparation for treating leukemia caused by deficiency of both yin and yang and its preparing process
CN105456447A (en) Folium artemisiae argyi-containing traditional Chinese medicine composition with function of promoting blood circulation to remove stasis and preparation method thereof
CN105943701A (en) Application of medicine with functions of tonifying qi and promoting blood circulation to preparation of medicines for treating insomnia
CN106924483B (en) Traditional Chinese medicine compound preparation for treating leukemia caused by spleen-kidney yang deficiency and preparation method thereof
CN101130039A (en) Shenling Biochemical Oral Liquid
CN1123160A (en) Chuanshentong injection and its preparation process and formula

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication